Otsuka Holdings
4578.T
$40.16
Share price
-1.07%
Change (1 day)
22.29%
Change (1 year)
Categories
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.
Earnings for Otsuka Holdings (4578.T)
Earnings in 2023 (TTM): $1.05 B
According to Otsuka Holdings 's latest financial reports the company's current earnings (TTM) are $1.05 B. In 2022 the company made an earning of $1.32 B a decrease over its 2021 earnings that were of $1.52 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Otsuka Holdings from 2010 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $1.05 B | -20.82% |
| 2022 | $1.32 B | -13.04% |
| 2021 | $1.52 B | -19.69% |
| 2020 | $1.90 B | 13.78% |
| 2019 | $1.67 B | 52.13% |
| 2018 | $1.09 B | 11.32% |
| 2017 | $0.98 B | -36.26% |
| 2016 | $1.54 B | 31.64% |
| 2015 | $1.17 B | |
| 2013 | $2.44 B | 33.73% |
| 2012 | $1.82 B | -4.78% |
| 2011 | $1.92 B | 46.23% |
| 2010 | $1.31 B |